GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 833 filers reported holding GLAXOSMITHKLINE PLC in Q2 2020. The put-call ratio across all filers is 0.95 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $105,000 | -34.8% | 2,412 | -34.9% | 0.00% | -25.0% |
| Q1 2022 | $161,000 | -1.2% | 3,707 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $163,000 | +1.9% | 3,707 | -11.3% | 0.00% | 0.0% |
| Q3 2021 | $160,000 | -53.5% | 4,180 | -51.5% | 0.00% | -55.6% |
| Q2 2021 | $344,000 | +12.1% | 8,620 | 0.0% | 0.01% | +12.5% |
| Q1 2021 | $307,000 | -5.2% | 8,620 | -2.3% | 0.01% | -20.0% |
| Q4 2020 | $324,000 | +17.4% | 8,820 | +20.4% | 0.01% | -9.1% |
| Q3 2020 | $276,000 | -7.4% | 7,325 | 0.0% | 0.01% | -8.3% |
| Q2 2020 | $298,000 | -5.4% | 7,325 | -12.0% | 0.01% | -20.0% |
| Q1 2020 | $315,000 | -23.2% | 8,325 | -4.6% | 0.02% | 0.0% |
| Q4 2019 | $410,000 | +9.9% | 8,725 | 0.0% | 0.02% | -6.2% |
| Q3 2019 | $373,000 | -1.6% | 8,725 | -7.7% | 0.02% | -5.9% |
| Q2 2019 | $379,000 | -15.6% | 9,454 | -11.9% | 0.02% | -15.0% |
| Q1 2019 | $449,000 | -3.2% | 10,731 | -11.6% | 0.02% | -9.1% |
| Q4 2018 | $464,000 | -2.3% | 12,141 | +2.5% | 0.02% | +22.2% |
| Q3 2018 | $475,000 | -21.1% | 11,841 | -20.7% | 0.02% | -30.8% |
| Q2 2018 | $602,000 | -10.1% | 14,941 | -12.8% | 0.03% | -13.3% |
| Q1 2018 | $670,000 | +17.5% | 17,132 | +6.6% | 0.03% | 0.0% |
| Q4 2017 | $570,000 | -26.0% | 16,071 | -15.2% | 0.03% | -33.3% |
| Q3 2017 | $770,000 | 0.0% | 18,960 | +6.2% | 0.04% | -10.0% |
| Q2 2017 | $770,000 | +10.2% | 17,860 | +7.5% | 0.05% | +6.4% |
| Q1 2017 | $699,000 | +8.9% | 16,610 | -0.3% | 0.05% | 0.0% |
| Q4 2016 | $642,000 | +44.9% | 16,661 | +62.2% | 0.05% | +4.4% |
| Q3 2016 | $443,000 | +10.2% | 10,273 | +10.8% | 0.04% | -4.3% |
| Q2 2016 | $402,000 | +6.3% | 9,273 | -0.4% | 0.05% | +2.2% |
| Q1 2016 | $378,000 | +73.4% | 9,314 | +72.0% | 0.05% | +228.6% |
| Q4 2015 | $218,000 | +3.3% | 5,414 | -1.2% | 0.01% | -48.1% |
| Q3 2015 | $211,000 | – | 5,477 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
| Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
| KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
| Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
| Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
| EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
| Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
| Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
| CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
| CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |